Workflow from Scientific Research

Project outline. Cohort division into clinically relevant breast cancer subgroups and PAM50 molecular subtypes including which information was used to compare the screened and non-screened subpopulations. Patients without ER/HER2 information are not shown in the PAM50 division. Subsets surrounded by dotted lines were not included in the analyses (see Additional file 1 : Supplementary Methods)

DOI